PTGS1 and neoplasm: In a protein array, lysates of Ptgs1/Ptgs2−/− BRAFV600E early (day 4) tumors displayed 45-fold more CCL5 than COX-sufficient control tumor lysates and a minor (<2-fold) increase in CCL27A (Figures 3B and 3C).